About Market Research Forecast

MR Forecast provides premium market intelligence on deep technologies that can cause a high level of disruption in the market within the next few years. When it comes to doing market viability analyses for technologies at very early phases of development, MR Forecast is second to none. What sets us apart is our set of market estimates based on secondary research data, which in turn gets validated through primary research by key companies in the target market and other stakeholders. It only covers technologies pertaining to Healthcare, IT, big data analysis, block chain technology, Artificial Intelligence (AI), Machine Learning (ML), Internet of Things (IoT), Energy & Power, Automobile, Agriculture, Electronics, Chemical & Materials, Machinery & Equipment's, Consumer Goods, and many others at MR Forecast. Market: The market section introduces the industry to readers, including an overview, business dynamics, competitive benchmarking, and firms' profiles. This enables readers to make decisions on market entry, expansion, and exit in certain nations, regions, or worldwide. Application: We give painstaking attention to the study of every product and technology, along with its use case and user categories, under our research solutions. From here on, the process delivers accurate market estimates and forecasts apart from the best and most meaningful insights.

Products generically come under this phrase and may imply any number of goods, components, materials, technology, or any combination thereof. Any business that wants to push an innovative agenda needs data on product definitions, pricing analysis, benchmarking and roadmaps on technology, demand analysis, and patents. Our research papers contain all that and much more in a depth that makes them incredibly actionable. Products broadly encompass a wide range of goods, components, materials, technologies, or any combination thereof. For businesses aiming to advance an innovative agenda, access to comprehensive data on product definitions, pricing analysis, benchmarking, technological roadmaps, demand analysis, and patents is essential. Our research papers provide in-depth insights into these areas and more, equipping organizations with actionable information that can drive strategic decision-making and enhance competitive positioning in the market.

About Market Research Forecast

U.S. Nasal Spray Market

U.S. Nasal Spray Market Is Set To Reach Billions By 2033, Growing At A CAGR Of 8.8

U.S. Nasal Spray Market by Product Type (Corticosteroids, Salt Water Solutions, Topical Decongestants, Antihistamine, Others), by Application (Nasal Allergies, Cold, Asthma, Others), by Patient Type (Pediatric, Adults), by Type (Prescription, Over-the-Counter), by Distribution Channel (Drug Stores & Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), by Forecast 2026-2034

Apr 2 2025

Base Year: 2025

150 Pages

U.S. Nasal Spray Market Is Set To Reach Billions By 2033, Growing At A CAGR Of 8.8

Key Insights

The U.S. nasal spray market, valued at approximately $5 billion in 2025, is projected to experience robust growth, exhibiting a compound annual growth rate (CAGR) of 8.8% from 2025 to 2033. This expansion is fueled by several key drivers. Rising prevalence of respiratory ailments like allergies, common colds, and asthma, coupled with an aging population increasingly susceptible to these conditions, significantly boosts demand. Furthermore, the convenience and efficacy of nasal sprays compared to alternative treatments contribute to market growth. The market is segmented by product type (corticosteroids, saline solutions, topical decongestants, antihistamines, and others), application (nasal allergies, cold, asthma, and others), patient type (pediatric and adults), type (prescription and over-the-counter), and distribution channel (drug stores, hospital pharmacies, and online pharmacies). The competitive landscape includes major pharmaceutical companies such as GSK, Viatris, Bayer, and Johnson & Johnson, along with several smaller, specialized players. Innovation in formulation and delivery systems, such as the development of targeted therapies and improved drug delivery mechanisms, further propels market growth.

Growth within specific segments is expected to vary. Over-the-counter nasal sprays for allergies and common colds are likely to remain dominant due to ease of access and consumer preference. However, prescription nasal sprays, particularly corticosteroids for chronic conditions like asthma, are projected to see considerable growth driven by increased diagnosis and treatment rates. The online pharmacy channel is anticipated to gain traction, reflecting broader e-commerce trends in healthcare. While market expansion is expected, potential restraints include the emergence of biosimilar and generic competition impacting pricing and market share for branded products. Regulatory hurdles and potential side effects associated with certain nasal spray formulations also pose challenges to continued growth. However, ongoing research and development efforts aimed at safer and more effective nasal sprays should mitigate these risks to some degree.

U.S. Nasal Spray Market Market Size and Forecast (2024-2030) — U.S. Nasal Spray Market Company Market Share

U.S. Nasal Spray Market Trends

The U.S. nasal spray market, valued at USD X billion in 2025, is poised for significant growth, projected to reach USD Y billion by 2033. This expansion is driven by a confluence of factors, including the rising prevalence of respiratory ailments, increasing awareness of convenient and effective nasal drug delivery, and the introduction of innovative products. The market demonstrates a diverse landscape, encompassing various product types catering to a wide range of applications. Over-the-counter (OTC) nasal sprays dominate the market share, driven by easy accessibility and self-treatment for common cold and allergies. However, prescription nasal sprays are witnessing a steady rise due to the increasing prevalence of chronic conditions like asthma and nasal allergies requiring specialized treatment. The market is also witnessing a shift towards technologically advanced nasal spray formulations focusing on improved efficacy and patient comfort. This includes the development of targeted drug delivery systems that enhance the bioavailability of active ingredients and minimize potential side effects. Competition among established pharmaceutical giants and emerging biotech companies is intensifying, leading to continuous innovation in product development and marketing strategies. Furthermore, increasing focus on personalized medicine has spurred the development of tailored nasal spray formulations catering to specific patient needs and conditions. The market displays regional variations, with higher demand in urban areas compared to rural regions, influenced by factors like healthcare infrastructure, access to information and higher disposable income. Future growth prospects are promising, driven by ongoing research and development of advanced nasal spray formulations, alongside the rise of telehealth and remote patient monitoring, increasing the accessibility of nasal spray medications.

Driving Forces: What's Propelling the U.S. Nasal Spray Market

Several key factors are driving the growth of the U.S. nasal spray market. The increasing prevalence of respiratory illnesses, including allergic rhinitis, common cold, and asthma, is a primary driver. The aging population, with its associated higher susceptibility to respiratory conditions, fuels the demand for effective and convenient treatment options like nasal sprays. The convenience and ease of use of nasal sprays compared to oral or injectable medications contribute significantly to their popularity among consumers. Furthermore, advancements in nasal spray technology, including the development of improved formulations with enhanced efficacy and reduced side effects, are expanding the market. The growing awareness among consumers regarding the benefits of nasal sprays for various respiratory conditions, fueled by effective marketing campaigns and increased physician recommendations, is boosting market growth. The rising healthcare expenditure in the United States and greater accessibility to healthcare services are additional contributing factors. The expansion of online pharmacies and e-commerce platforms has also simplified the purchasing process, increasing accessibility and market reach. Lastly, regulatory approvals for innovative nasal spray products are steadily expanding the range of available therapies, attracting a broader patient base and further stimulating market expansion.

Challenges and Restraints in U.S. Nasal Spray Market

Despite its promising growth trajectory, the U.S. nasal spray market faces several challenges. The intense competition among numerous established and emerging players necessitates continuous innovation and cost-effective manufacturing to maintain market share. Stringent regulatory requirements and the lengthy approval processes for new products represent significant hurdles for market entrants. The potential for adverse effects, such as nasal irritation and dryness, can limit the acceptance and usage of certain nasal sprays. Price sensitivity among consumers, especially for OTC products, necessitates competitive pricing strategies to ensure market penetration and competitiveness. Fluctuations in raw material costs and economic downturns can also negatively impact profitability. The increasing prevalence of generic nasal spray formulations creates pricing pressure for branded products. Additionally, the development and marketing of new nasal spray products require significant investment in research and development, posing a financial burden for companies. Finally, concerns about the long-term effects of certain nasal spray ingredients on nasal mucosa health and systemic absorption can influence consumer choice and potentially hinder market growth.

Key Region or Country & Segment to Dominate the Market

The U.S. nasal spray market exhibits considerable regional variations in growth and consumption patterns. While detailed regional breakdowns might vary depending on the data sources, the overall trend shows that densely populated areas with high concentrations of healthcare facilities and higher disposable income often witness increased demand.

Over-the-Counter (OTC) Segment Dominance: The OTC segment holds a substantial share, driven by ease of access and self-treatment for common ailments like allergies and the common cold. This is likely to continue being a significant driver of market growth.
Nasal Allergies Application: Nasal allergies constitute a major application segment, reflecting the widespread prevalence of allergic rhinitis in the U.S. population. This segment will continue expanding alongside the increasing awareness of allergy management.
Drug Stores & Retail Pharmacies: The majority of nasal sprays are purchased through this channel due to accessibility and immediate availability. This distribution channel is expected to maintain a leading market share.

In Paragraph Form: The U.S. nasal spray market is characterized by a geographically dispersed demand, with higher consumption in urban centers due to higher population densities, better healthcare access, and a higher average income level. However, the OTC segment is the clear market leader due to its ease of access and suitability for self-treatment of common conditions. The application of nasal sprays for allergies is another dominant segment, largely influenced by the increasing prevalence of allergic rhinitis across the population. Finally, drug stores and retail pharmacies serve as the most prominent distribution channels due to their widespread presence and convenient accessibility for consumers. This combined dominance of the OTC segment, the allergies application, and drug store distribution points towards the key dynamics within the U.S. nasal spray market.

Growth Catalysts in U.S. Nasal Spray Industry

Several factors are poised to fuel continued growth in the U.S. nasal spray industry. The development of novel drug delivery systems, improving efficacy and minimizing side effects, presents significant opportunities. Furthermore, an expanding pipeline of innovative nasal spray formulations targeting niche therapeutic areas and patient populations will further stimulate market expansion. Growing investment in research and development, coupled with favorable regulatory environments, will lead to new product approvals and increased market competition. This, along with heightened awareness and understanding of respiratory health issues within the general population, promises consistent growth for the industry for the foreseeable future.

Leading Players in the U.S. Nasal Spray Market

GSK plc (GSK plc)
Viatris Inc. (Viatris Inc.)
Emergent Devices, Inc.
Cipla, Inc.
Bayer AG (Bayer AG)
Aurena Laboratories
Aytu Health (Innovus Pharmaceutical)
The Procter & Gamble Company (The Procter & Gamble Company)
AstraZeneca (AstraZeneca)
Johnson & Johnson Services, Inc. (Johnson & Johnson Services, Inc.)

Significant Developments in U.S. Nasal Spray Sector

August 2023: Emergent BioSolutions Inc. announced over-the-counter access for its NARCAN Naloxone HCl 4 mg nasal spray to treat opioid overdose.
August 2021: Hikma Pharmaceuticals PLC announced the launch of KLOXXADO (naloxone HCl) nasal spray 8mg in the U.S. for the emergency treatment of opioid overdose for adult and pediatric patients.
August 2020: Janssen Pharmaceutical Companies of Johnson & Johnson announced that its nasal spray product SPRAVATO (esketamine) received U.S. FDA approval to treat depressive symptoms in adults.

Comprehensive Coverage U.S. Nasal Spray Market Report

This report provides a detailed analysis of the U.S. nasal spray market, covering market size, growth drivers, challenges, key segments, leading players, and significant developments. It offers insights into the market dynamics, future growth potential, and competitive landscape, providing valuable information for stakeholders across the pharmaceutical industry. The comprehensive nature of this report enables informed decision-making and strategic planning for companies operating in or seeking to enter the U.S. nasal spray market. The extensive data and analysis presented, covering the period from 2019 to 2033, provide a thorough understanding of historical trends, current market conditions, and future projections.

U.S. Nasal Spray Market Segmentation

1. Product Type
- 1.1. Corticosteroids
- 1.2. Salt Water Solutions
- 1.3. Topical Decongestants
- 1.4. Antihistamine
- 1.5. Others
2. Application
- 2.1. Nasal Allergies
- 2.2. Cold
- 2.3. Asthma
- 2.4. Others
3. Patient Type
- 3.1. Pediatric
- 3.2. Adults
4. Type
- 4.1. Prescription
- 4.2. Over-the-Counter
5. Distribution Channel
- 5.1. Drug Stores & Retail Pharmacies
- 5.2. Hospital Pharmacies
- 5.3. Online Pharmacies

U.S. Nasal Spray Market Segmentation By Geography

U.S. Nasal Spray Market Market Share by Region - Global Geographic Distribution — U.S. Nasal Spray Market Regional Market Share

Geographic Coverage of U.S. Nasal Spray Market

Higher Coverage

Lower Coverage

No Coverage

U.S. Nasal Spray Market REPORT HIGHLIGHTS

Aspects	Details
Study Period	2020-2034
Base Year	2025
Estimated Year	2026
Forecast Period	2026-2034
Historical Period	2020-2025
Growth Rate	CAGR of 8.8 % % from 2020-2034
Segmentation	By Product Type Corticosteroids Salt Water Solutions Topical Decongestants Antihistamine Others By Application Nasal Allergies Cold Asthma Others By Patient Type Pediatric Adults By Type Prescription Over-the-Counter By Distribution Channel Drug Stores & Retail Pharmacies Hospital Pharmacies Online Pharmacies By Geography

1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
- 2.1. Introduction
3. Market Dynamics
- 3.1. Introduction
- - 3.2. Market Drivers
  - - 3.2.1. Product Innovations and Launches to Drive Market Growth
- - 3.3. Market Restrains
  - - 3.3.1. Adverse Side-effects and Availability of Alternative Treatment Options May Hamper Market Growth
- - 3.4. Market Trends
  - - 3.4.1. Growing Preference for Saline-based Nasal Sprays
4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
5. U.S. Nasal Spray Market Analysis, Insights and Forecast, 2020-2032
- 5.1. Market Analysis, Insights and Forecast - by Product Type
  - 5.1.1. Corticosteroids
  - 5.1.2. Salt Water Solutions
  - 5.1.3. Topical Decongestants
  - 5.1.4. Antihistamine
  - 5.1.5. Others
- 5.2. Market Analysis, Insights and Forecast - by Application
  - 5.2.1. Nasal Allergies
  - 5.2.2. Cold
  - 5.2.3. Asthma
  - 5.2.4. Others
- 5.3. Market Analysis, Insights and Forecast - by Patient Type
  - 5.3.1. Pediatric
  - 5.3.2. Adults
- 5.4. Market Analysis, Insights and Forecast - by Type
  - 5.4.1. Prescription
  - 5.4.2. Over-the-Counter
- 5.5. Market Analysis, Insights and Forecast - by Distribution Channel
  - 5.5.1. Drug Stores & Retail Pharmacies
  - 5.5.2. Hospital Pharmacies
  - 5.5.3. Online Pharmacies
- 5.6. Market Analysis, Insights and Forecast - by Region
  - 5.6.1.
6. Competitive Analysis
- 6.1. Market Share Analysis 2025
- - 6.2. Company Profiles
  - - 6.2.1 GSK plc (U.K.)
      6.2.1.1. Overview
      6.2.1.2. Products
      6.2.1.3. SWOT Analysis
      6.2.1.4. Recent Developments
      6.2.1.5. Financials (Based on Availability)
    - 6.2.2 Viatris Inc. (U.S.)
      6.2.2.1. Overview
      6.2.2.2. Products
      6.2.2.3. SWOT Analysis
      6.2.2.4. Recent Developments
      6.2.2.5. Financials (Based on Availability)
    - 6.2.3 Emergent Devices Inc. (U.S.)
      6.2.3.1. Overview
      6.2.3.2. Products
      6.2.3.3. SWOT Analysis
      6.2.3.4. Recent Developments
      6.2.3.5. Financials (Based on Availability)
    - 6.2.4 Cipla Inc. (India)
      6.2.4.1. Overview
      6.2.4.2. Products
      6.2.4.3. SWOT Analysis
      6.2.4.4. Recent Developments
      6.2.4.5. Financials (Based on Availability)
    - 6.2.5 Bayer AG (Germany)
      6.2.5.1. Overview
      6.2.5.2. Products
      6.2.5.3. SWOT Analysis
      6.2.5.4. Recent Developments
      6.2.5.5. Financials (Based on Availability)
    - 6.2.6 Aurena Laboratories (Sweden)
      6.2.6.1. Overview
      6.2.6.2. Products
      6.2.6.3. SWOT Analysis
      6.2.6.4. Recent Developments
      6.2.6.5. Financials (Based on Availability)
    - 6.2.7 Aytu Health (Innovus Pharmaceutical) (U.S.)
      6.2.7.1. Overview
      6.2.7.2. Products
      6.2.7.3. SWOT Analysis
      6.2.7.4. Recent Developments
      6.2.7.5. Financials (Based on Availability)
    - 6.2.8 The Procter & Gamble Company (U.S.)
      6.2.8.1. Overview
      6.2.8.2. Products
      6.2.8.3. SWOT Analysis
      6.2.8.4. Recent Developments
      6.2.8.5. Financials (Based on Availability)
    - 6.2.9 AstraZeneca (U.K.)
      6.2.9.1. Overview
      6.2.9.2. Products
      6.2.9.3. SWOT Analysis
      6.2.9.4. Recent Developments
      6.2.9.5. Financials (Based on Availability)
    - 6.2.10 Johnson & Johnson Services Inc. (U.S.)
      6.2.10.1. Overview
      6.2.10.2. Products
      6.2.10.3. SWOT Analysis
      6.2.10.4. Recent Developments
      6.2.10.5. Financials (Based on Availability)

List of Figures

Figure 1: U.S. Nasal Spray Market Revenue Breakdown (USD Billion, %) by Product 2025 & 2033
Figure 2: U.S. Nasal Spray Market Share (%) by Company 2025

List of Tables

Table 1: U.S. Nasal Spray Market Revenue USD Billion Forecast, by Product Type 2020 & 2033
Table 2: U.S. Nasal Spray Market Volume K Units Forecast, by Product Type 2020 & 2033
Table 3: U.S. Nasal Spray Market Revenue USD Billion Forecast, by Application 2020 & 2033
Table 4: U.S. Nasal Spray Market Volume K Units Forecast, by Application 2020 & 2033
Table 5: U.S. Nasal Spray Market Revenue USD Billion Forecast, by Patient Type 2020 & 2033
Table 6: U.S. Nasal Spray Market Volume K Units Forecast, by Patient Type 2020 & 2033
Table 7: U.S. Nasal Spray Market Revenue USD Billion Forecast, by Type 2020 & 2033
Table 8: U.S. Nasal Spray Market Volume K Units Forecast, by Type 2020 & 2033
Table 9: U.S. Nasal Spray Market Revenue USD Billion Forecast, by Distribution Channel 2020 & 2033
Table 10: U.S. Nasal Spray Market Volume K Units Forecast, by Distribution Channel 2020 & 2033
Table 11: U.S. Nasal Spray Market Revenue USD Billion Forecast, by Region 2020 & 2033
Table 12: U.S. Nasal Spray Market Volume K Units Forecast, by Region 2020 & 2033
Table 13: U.S. Nasal Spray Market Revenue USD Billion Forecast, by Product Type 2020 & 2033
Table 14: U.S. Nasal Spray Market Volume K Units Forecast, by Product Type 2020 & 2033
Table 15: U.S. Nasal Spray Market Revenue USD Billion Forecast, by Application 2020 & 2033
Table 16: U.S. Nasal Spray Market Volume K Units Forecast, by Application 2020 & 2033
Table 17: U.S. Nasal Spray Market Revenue USD Billion Forecast, by Patient Type 2020 & 2033
Table 18: U.S. Nasal Spray Market Volume K Units Forecast, by Patient Type 2020 & 2033
Table 19: U.S. Nasal Spray Market Revenue USD Billion Forecast, by Type 2020 & 2033
Table 20: U.S. Nasal Spray Market Volume K Units Forecast, by Type 2020 & 2033
Table 21: U.S. Nasal Spray Market Revenue USD Billion Forecast, by Distribution Channel 2020 & 2033
Table 22: U.S. Nasal Spray Market Volume K Units Forecast, by Distribution Channel 2020 & 2033
Table 23: U.S. Nasal Spray Market Revenue USD Billion Forecast, by Country 2020 & 2033
Table 24: U.S. Nasal Spray Market Volume K Units Forecast, by Country 2020 & 2033

Methodology

Step 1 - Identification of Relevant Samples Size from Population Database

Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segments, product, and application.

Note*: In applicable scenarios

Step 3 - Data Sources

Primary Research

Web Analytics
Survey Reports
Research Institute
Latest Research Reports
Opinion Leaders

Secondary Research

Annual Reports
White Paper
Latest Press Release
Industry Association
Paid Database
Investor Presentations

Step 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally, after gathering mixed and scattered data from a wide range of sources, data is triangulated and correlated to come up with estimated figures which are further validated through primary mediums or industry experts, opinion leaders.

Frequently Asked Questions

1. What is the projected Compound Annual Growth Rate (CAGR) of the U.S. Nasal Spray Market?

The projected CAGR is approximately 8.8 % %.

2. Which companies are prominent players in the U.S. Nasal Spray Market?

Key companies in the market include GSK plc (U.K.), Viatris Inc. (U.S.), Emergent Devices, Inc. (U.S.), Cipla, Inc. (India), Bayer AG (Germany), Aurena Laboratories (Sweden), Aytu Health (Innovus Pharmaceutical) (U.S.), The Procter & Gamble Company (U.S.), AstraZeneca (U.K.), Johnson & Johnson Services, Inc. (U.S.).

3. What are the main segments of the U.S. Nasal Spray Market?

The market segments include Product Type, Application, Patient Type, Type, Distribution Channel.

4. Can you provide details about the market size?

The market size is estimated to be USD XXX USD Billion as of 2022.

5. What are some drivers contributing to market growth?

Product Innovations and Launches to Drive Market Growth.

6. What are the notable trends driving market growth?

Growing Preference for Saline-based Nasal Sprays.

7. Are there any restraints impacting market growth?

Adverse Side-effects and Availability of Alternative Treatment Options May Hamper Market Growth.

8. Can you provide examples of recent developments in the market?

August 2023: Emergent BioSolutions Inc. announced over-the-counter access for its NARCAN Naloxone HCl 4 mg nasal spray to treat opioid overdose.

9. What pricing options are available for accessing the report?

Pricing options include single-user, multi-user, and enterprise licenses priced at USD 2850, USD 3850, and USD 4850 respectively.

10. Is the market size provided in terms of value or volume?

The market size is provided in terms of value, measured in USD Billion and volume, measured in K Units.

11. Are there any specific market keywords associated with the report?

Yes, the market keyword associated with the report is "U.S. Nasal Spray Market," which aids in identifying and referencing the specific market segment covered.

12. How do I determine which pricing option suits my needs best?

The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

13. Are there any additional resources or data provided in the U.S. Nasal Spray Market report?

While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.

14. How can I stay updated on further developments or reports in the U.S. Nasal Spray Market?

To stay informed about further developments, trends, and reports in the U.S. Nasal Spray Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.

Get Free Sample

Pre Order Enquiry Request discount

Pricing

Tailored for you

In-depth Analysis Tailored to Specified Regions or Segments
Company Profiles Customized to User Preferences
Comprehensive Insights Focused on Specific Segments or Regions
Customized Evaluation of Competitive Landscape to Meet Your Needs
Tailored Customization to Address Other Specific Requirements

Ask for customization

The response was good, and I got what I was looking for as far as the report. Thank you for that.

Erik Perison

US TPS Business Development Manager at Thermon

As requested- presale engagement was good, your perseverance, support and prompt responses were noted. Your follow up with vm’s were much appreciated. Happy with the final report and post sales by your team.

Shankar Godavarti

Global Product, Quality & Strategy Executive- Principal Innovator at Donaldson

I have received the report already. Thanks you for your help.it has been a pleasure working with you. Thank you againg for a good quality report